TechMARK movers: Vislink's Chinese joint venture

There is good news today for broadcast and CCTV technology supplier Vislink. Following the recent disappointing interim results Vislink has announced a joint venture in China and this has helped it claw back much of the recent share price fall. The Beijing-based joint venture will be Vislink's master distributor in China. BTG is paying Nycomed around £10m for the accelerated return of rights to antivenom CroFab and DigiFab, a treatment for life-threatening digoxin toxicity or overdose. BTG will report higher 2010 revenues than expected because of this deal. The anticipated revenue is £93m-£97m and the agreement should be slightly earnings enhancing this year. The BTG cash position should be £45m-£50m at the end of 2010. FTSE TechMARK - RisersVislink (VLK) 18.00p +18.03%Emblaze (BLZ) 42.00p +9.09%Intec Telecom Systems (ITL) 62.50p +8.70%ARM Holdings (ARM) 361.00p +6.87%RM Group (RM.) 134.75p +5.27%Oxford Biomedica (OXB) 9.40p +4.68%Torotrak (TRK) 21.50p +4.65%SDL International (SDL) 566.50p +3.94%Ricardo Group (RCDO) 263.00p +3.75%Alterian (ALN) 183.00p +2.23%FTSE TechMARK - FallersAntisoma (ASM) 5.60p -6.04%Kewill (KWL) 97.00p -4.90%Wolfson Microelectronics (WLF) 193.75p -3.37%Renishaw (RSW) 849.00p -2.80%BTG (BGC) 200.50p -2.48%Anite Group (AIE) 44.50p -2.20%Renovo Group (RNVO) 22.75p -2.15%Corin Group (CRG) 54.00p -1.82%Parity Group (PTY) 7.25p -1.76%NCC Group (NCC) 442.00p -1.45%